[PLX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 22.06%
YoY- 4.52%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 10,345 14,183 12,054 10,790 14,248 663 7,526 5.44%
PBT -1,719 -3,567 -4,199 -4,437 -3,560 -15,544 -11,437 -27.07%
Tax 133 442 96 118 34 230 8 59.72%
NP -1,852 -4,009 -4,199 -4,437 -3,560 -15,544 -11,437 -26.16%
Tax Rate - - - - - - - -
Total Cost 12,197 18,192 16,253 15,227 17,808 16,207 18,963 -7.08%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -17.90 -28.27 -34.83 -41.12 -24.99 -2,344.49 -151.97 -29.97%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.03 -0.08 -0.09 -0.14 -0.24 -1.05 -0.86 -42.82%
EPS Diluted -0.02 -0.08 -0.09 -0.14 -0.24 -1.05 -0.86 -46.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.